Related Experiment Videos
The interferon regulatory factors and oncogenesis
1Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Japan.
Seminars in Cancer Biology
|August 11, 2000
Summary
Interferon regulatory factors (IRFs) are key in host defense and cell growth. This review details IRF family roles, especially IRF-1, in oncogenesis and host defense regulation.
Area of Science:
- Molecular Biology
- Immunology
- Cancer Research
Background:
- Interferon regulatory factors (IRFs) were initially identified for their role in regulating the type-I interferon (IFN-alpha/beta) system.
- The IRF family has expanded to nine members, with diverse functions beyond interferon regulation.
- IRF-1, in particular, has demonstrated significant functional diversity in cellular responses, including host defense and oncogenesis.
Purpose of the Study:
- To review the current understanding of the IRF family's involvement in oncogenesis.
- To highlight the specific role of IRF-1 in cancer development and regulation.
- To summarize the critical involvement of IRF members in cell growth and oncogenesis based on gene disruption studies.
Main Methods:
- Literature review of studies on interferon regulatory factors (IRFs).
- Analysis of gene disruption studies implicating IRF members in cell growth and oncogenesis.
- Focus on research concerning IRF-1's functional diversity in host defense and oncogenesis.
Main Results:
- The IRF family comprises nine members, each with potential roles in cell regulation.
- Gene disruption studies confirm the involvement of several IRF members in controlling cell growth and oncogenesis.
- IRF-1 exhibits a broad range of functions in host defense and is implicated in oncogenesis.
Conclusions:
- IRF family members play critical roles in regulating cell growth and are implicated in oncogenesis.
- IRF-1 is a key factor with diverse functions relevant to host defense and cancer development.
- Further research into the IRF family is crucial for understanding and potentially targeting oncogenesis.